Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Adds BioNTech comment)By Arno SchuetzeFRANKFURT, Dec 27 (Reuters) - Germany's coronavirus vaccination campaign faced delays in several cities on Sunday after temperature trackers showed that about 1,000 of the shots made by BioNTech and Pfizer ma...
Read more(Adds detail)By Arno SchuetzeFRANKFURT, Dec 27 (Reuters) - Germany's coronavirus vaccination campaign faced delays in several cities on Sunday after temperature trackers showed that about 1,000 of the shots made by BioNTech and Pfizer may not have...
Read more(Corrects to BioNtech spokeswoman, not Pfizer, paragraphs 4-5)By Arno SchuetzeFRANKFURT, Dec 27 (Reuters) - Germany's coronavirus vaccination campaign faced delays in several cities on Sunday after temperature trackers showed that about 1,000 of th...
Read more
(Sharecast News) - The chief executive of AstraZeneca has raised hopes its vaccine with Oxford is more effective than first thought amid the rapid spread of the new UK virus strain across the globe. Pascal Soriot said he believed researchers had found the "winning formula" using two doses and promised to publish the results as reports suggested the UK regulator could approve the jab within days. - Sunday Telegraph
Read more(Adds comment from Pfizer, BioNTech)* Goal is to offer vaccine to all adults through 2021* 'Thank God,' says first recipient in Spain, 96* Delays in some German cities over cooling concerns* Urgency as new virus variants crop upBy Isla Binnie and Gis...
Read more(Adds BioNTech response to German districts, Dutch delay in inoculations)* Goal is to offer vaccine to all adults through 2021* 'Thank God,' says first recipient in Spain, 96* Delays in some German cities over cooling concerns* Urgency as new virus ...
Read more(Adds detail on German delays, detail, background, edits)* Goal is to offer vaccine to all adults through 2021* 'Thank God,' says first recipient in Spain, 96* Delays in some German cities over cooling concerns* Urgency as new virus variants crop upB...
Read more(Adds quotes from Macron, Greece, Norway, detail and background on new variants, German glitches)* Goal is to offer vaccine to all adults through 2021* EU has secured contracts for 2 billion-plus doses* Frontline workers and elderly among those prio...
Read more(Corrects source to BioNTech, not Pfizer, paragraphs 14-15)* Goal is to offer vaccine to all adults through 2021* 'Thank God,' says first recipient in Spain, 96* Delays in some German cities over cooling concerns* Urgency as new virus variants crop u...
Read more
AstraZeneca Chief Believes Vaccine Will Work Against UK Virus Strain
Read moreLONDON, Dec 26 (Reuters) - The United Kingdom will roll out Oxford University’s COVID-19 vaccine from Jan. 4, according to plans being drawn up by ministers, The Sunday Telegraph reported.The government hopes to give the first dose of either the ...
Read more(Updates with health minister confirmation on new variant cases)By Kiyoshi Takenaka and Tetsushi KajimotoTOKYO, Dec 25 (Reuters) - Japanese Prime Minister Yoshihide Suga urged the nation on Friday to spend a quiet New Year period without the usual...
Read more(Updates with reports on first cases of mutated coronavirus)By Kiyoshi Takenaka and Tetsushi KajimotoTOKYO, Dec 25 (Reuters) - Japanese Prime Minister Yoshihide Suga urged the nation on Friday to spend a quiet New Year period without the usual soci...
Read more(Recasts with Suga, Omit comments)By Kiyoshi Takenaka and Tetsushi KajimotoTOKYO, Dec 25 (Reuters) - Japanese Prime Minister Yoshihide Suga urged the nation on Friday to spend a quiet New Year period without the usual social gatherings to prevent t...
Read more(Adds details from statement, vaccine-related background)Dec 24 (Reuters) - More than 600,000 people in the United Kingdom have received the first dose of the Pfizer-BioNTech COVID-19 vaccine since inoculations began in the country earlier this mo...
Read more
Last checked at